Insulin Products Return to Non-Preferred Status on September 18, 2020

Insulin Products Return to Non-Preferred Status on September 18, 2020

FirstCare temporarily removed the non-preferred status on April 2 in response to reported drug shortages for insulin products in the "Hypoglycemics, Insulins" drug class. FirstCare will reverse this change in status because of sufficient availability in the market. Beginning September 18, 2020 the formulary will reflect the PDL status changes for all non-preferred insulin products. For additional information and a list of preferred PDL NDCs please click here.

Send to a Friend

* Required field

Captcha The math problem above is intended to reduce spam.